 Below is a look at some of the headlines for companies that made news in the healthcare sector on March 28, 2012.
|
|
Read more...
|
 After spending more than 20 years in the pharmaceutical industry with companies like GlaxoSmithKline and others, Mark A. Sirgo joined BioDelivery Sciences (Nasdaq:BDSI) in August 2004 as Senior Vice President of Commercialization and Corporate Development upon the acquisition of Arius Pharmaceuticals-- a company which he co-founded.
|
|
Read more...
|
Below is a look at some of the headlines for companies that made news in the healthcare sector on March 27, 2012.
|
|
Read more...
|
 The FDA has asked drugmaker MAP Pharmaceuticals (NASDAQ:MAPP) to address issues tied to chemistry, manufacturing and controls before it can decide whether to approve its potential migraine treatment Levadex. The company's shares dropped dramatically in premarket trading onTuesday.
|
|
Read more...
|
Below is a look at some of the headlines for companies that made news in the healthcare sector on March 26, 2012.
|
|
Read more...
|
 Last week, shares of Pozen Inc. (NASDAQ:POZN), a developer of novel pharmacologic agents primarily for pain and pain-related conditions, rose the most in four months after announcing positive top-line results from two pivotal Phase 3 clinical trials. Will shares continue higher based on fundamentals and new upcoming catalysts?
|
|
Read more...
|
|
Hoji Alimi, founder and CEO of Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) in an exclusive, candid interview with BioMedReports, answers questions about whether his company will ever become a profitable and successfully commercialized biotechnology firm.
|
|
Read more...
|
Omeros Corporation (Nasdaq:OMER) is a pharmaceutical company that is developing a new drug system for treating patients that are undergoing surgery.
